Special Issue "Nanomaterial-Based Contrast Agents for Biomedical Imaging"
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 31 March 2024 | Viewed by 2007
Special Issue Editors
Interests: fluorescence imaging; photoacoustic imaging; microscopy; wide-field imaging; two photon imaging; second harmonic imaging; molecular imaging probes
Special Issues, Collections and Topics in MDPI journals
Interests: microneedles; microparticles; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Precision imaging is critical for the theranostics of diseases, as it provides insightful guidance for medical personnel to define pathological processes and manage diseases. Nowadays, nanomaterials have emerged as promising alternatives to conventional contrast agents for biomedical imaging since they offer high-fidelity imaging due to an improved delivery efficiency and accumulation in the diseased tissues. With the assistance of advanced imaging techniques, these nanomaterials could provide diverse imaging modalities, such as fluorescence imaging, photoacoustic imaging, magnetic resonance imaging, micro-CT imaging, X-ray imaging, etc. More attractively, they could also be used as therapeutic agents to assist with therapy by harnessing the optical, acoustic, magnetic, and chemodynamic energies and converting them into therapeutic output. The theranostic performance of nanomaterials could be improved through the delicate tuning of the target ability, responsive release behavior, quantum yield, etc. Therefore, nanomaterials hold great promise for precision theranostics of diseases.
This Special Issue aims to highlight the recent advances in the development of nanomaterials for contrast agents and biomedical imaging. Original research papers and reviews papers are all welcome.
Dr. Bing Guo
Dr. Tingting Peng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterial
- contrast agent
- theranostic agents
- imaging techniques
- diseases